Longitude Prize on ALS

Join us in bringing AI to the fight against ALS, the most common form of motor neurone disease. Learn more at our website, and follow us for updates.

[Longitude Prize on ALS @longitude_prize]

🧠 The #LongitudePrizeOnALS is now live!

This £7.5M challenge invites innovators across #biotech, #AI, and #data science to help accelerate #ALS treatment discovery.

Join us in bringing AI to the fight against ALS.
Learn more: https://t.co/ZnMcBIi7jT

#LPALS #MND

[Longitude Prize on ALS @longitude_prize]

We're proud to announce the 20 Discovery Award winners have been selected for the #LongitudePrizeOnALS – each receiving £100k to use AI to identify new drug targets for the disease. Find out more 👉 https://t.co/sjghqgQldn
@Challenge_Works @mndassoc

[Longitude Prize on ALS @longitude_prize]

🚨 Final Call for the £7.5m (~$10m) Longitude Prize on ALS. Don’t miss your chance to make a real difference for those living with #ALS (the most common form of #MND).

Submit your application by 15:00 GMT (10:00 AM EST) tomorrow!

Apply here: https://t.co/3tkvcNEemH

[Longitude Prize on ALS @longitude_prize]

⏰1 week to go! Entries to the £7.5M (~$10M) Longitude Prize on ALS are closing next week – submit your application before Wednesday 3rd December 2025.

Your expertise could make the difference.

🔗Learn more and apply today: https://t.co/3tkvcNEMcf

[Longitude Prize on ALS @longitude_prize]

@OHENews estimates that eradicating ALS could deliver $143B+ in value over 10 years. The potential global value is huge. #ALS/#MND remains underfunded and breakthroughs are urgently needed.

Full report: https://t.co/k2ro3DkYId
Learn more about the Prize https://t.co/3tkvcNEMcf

[Longitude Prize on ALS @longitude_prize]

🚨 Only 2 weeks left to apply! The £7.5M (~$10M) Longitude Prize on ALS is closing soon – submit your application before 3 December 2025 and don’t miss your chance to make a real difference.

🔗 To learn more about the Prize, click here: https://t.co/3tkvcNEemH

[Longevity Technology @LongevityTech]

New analysis puts a multi-billion-dollar value on progress as Japan opens new scientific pathways for ALS discovery.

https://t.co/G8JFSwoHxY

#longevity #ALS #biotech #neuroscience #healthinnovation #drugdevelopment #futureofmedicine

[UK Consulate in SF @UKin_SF]

Just 3 weeks left to apply for the £7.5m, 5-year @longitude_prize on ALS! 🚨 We’re seeking global, cross-disciplinary teams to harness AI & the largest ALS dataset to discover new treatments and therapeutic targets. Apply by 3 Dec! https://t.co/bBx6rF2SnY

[Longitude Prize on ALS @longitude_prize]

Calling all AI and biotech innovators and researchers across India: applications for the Longitude Prize on ALS close on 3 December, and we’re looking for you: https://t.co/sjghqgQT2V

See @Taslimarif's latest piece for @DeccanHerald (@CCAMP_India) here https://t.co/UDYVzVkatD

[C-CAMP @CCAMP_India]

"The steps the country takes now could shape its ability to respond in the future."

In his latest opinion piece for @DeccanHerald, CCAMP Director-CEO @Taslimarif reflects on India’s AI-based drug discovery, research into diseases of ageing, and the impact of the Longitude Prize on ALS.

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects motor neurons, causing the brain to gradually lose its ability to control muscles and impacting mobility, speech, and breathing. It affects approximately 2–3 people per 100,000 individuals worldwide.

Read now: https://t.co/yc0hpVmzJw

Dr. Taslimarif Saiyed is a jury member on the @longitude_prize, the £7.5M global challenge for ALS treatment technologies.
Apply now: https://t.co/hSVXdhDL3O

@DrJitendraSingh @DBTIndia @rajesh_gokhale @IndiaDST @karandi65 @BIRAC_2012 @AIMtoInnovate @NITIAayog @NIMHANS_BLR @kris_sg @NCBS_Bangalore @DBT_inStem @DBT_NBRC @aiims_newdelhi @aiims_jodhpur @iitmadras @iiscbangalore @startupindia @ITBTGoK @Ktech_biotech @startupindia

[MND Association @mndassoc]

I have MND and I’m putting millions into finding a cure

#MND

https://t.co/kDOdtN91bQ

[Longitude Prize on ALS @longitude_prize]

Grateful to John Driskell Hopkins, or “Hop” - from the the Grammy Award–winning @zacbrownband and @HopOnACure - for his support for The Longitude Prize on ALS.

Living with #ALS himself, Hop has campaigned to raise awareness for those affected by this devastating disease.

[Longitude Prize on ALS @longitude_prize]

There's 1 month left to apply for the £7.5m (~$10m) Longitude Prize on ALS, start your application today https://t.co/3tkvcNEemH

#AIforGood #ALS #MND #Neuroscience

[Longitude Prize on ALS @longitude_prize]

We recently spoke to Paul Wright, Head of MND & Rare Dementias at @lifearc1

Paul details LifeArc's main ambitions, how the organisation is working to make #MND treatable and ultimately preventable, and why they joined the Prize.

🧬 Read more here: https://t.co/WGBg7S8P2i

[Taslimarif Saiyed @Taslimarif_IND]

Transforming ALS therapeutics!

Honoured to join the @longitude_prize Jury! The £7.5M global challenge for ALS treatment technologies.

We are looking for breakthrough innovative solutions for addressing Amyotrophic Lateral Sclerosis (#ALS), the most common form of motor neurone disease

Innovators in medical research, biotechnology, computational biology and AI with bold ideas, apply now: https://t.co/VQqEjeYrIt

@CCAMP_India

[Longitude Prize on ALS @longitude_prize]

We had the pleasure of catching up with @DrBrianDickie MBE, Chief Scientist at the @mndassoc, the principal funder of the £7.5M Longitude Prize on ALS.

📖 Read the full Q&A here: https://t.co/TMStRoZzNQ

[Longitude Prize on ALS @longitude_prize]

Join us at the @ALSTDI Summit in Boston, MA tomorrow to learn more about how we're bringing #AI and unprecedented data to the fight against #ALS, the most common form of motor neurone disease (#MND).

#LouGehrig #AIforGood #DrugDiscovery #HealthInnovation #Neurodegeneration

[ALS TDI @ALSTDI]

Summit day is almost here! 🙌 Join us this Friday for the ALS TDI Summit — a free conference sharing the latest breakthroughs in ALS research.

There’s still time to register to attend virtually 🌍
👉 https://t.co/SNm0rgU7fb

[C-CAMP @CCAMP_India]

Here's your chance to transform treatment for the most common form of motor neurone disease - #ALS, with your innovation!

#Innovators, apply for the @longitude_prize on Amyotrophic Lateral Sclerosis by Dec 3rd, 2025

Learn more: https://t.co/a70hHOJv09

The Longitude Prize on ALS is a £7.5m GBP [~$10m USD] international programme that seeks to incentivise the use of AI-based approaches to transform therapeutic discovery for the treatment of amyotrophic lateral sclerosis (ALS)

@Taslimarif @IndiaDST @DBTIndia @BIRAC_2012 @AIMtoInnovate @NITIAayog @NIMHANS_BLR @kris_sg @NCBS_Bangalore @DBT_inStem @DBT_NBRC @aiims_newdelhi @aiims_jodhpur @iitmadras @iiscbangalore @startupindia @ITBTGoK @Ktech_biotech @startupindia

[Longitude Prize on ALS @longitude_prize]

Join us at the #ASHG25 Annual Meeting in Boston, starting today!

Visit us at Booth 46, we’d love to meet you and discuss how the ~$10M Longitude Prize on ALS is harnessing #AI to transform the future of neurodegenerative disease treatment.

@Challenge_Works @GeneticsSociety

[Longitude Prize on ALS @longitude_prize]

Good morning #BiotechX! If you are interested in #AI for #drugdiscovery in #rarediseases and #neurodegeneration come by Booth 119 and Theatre 10 at 2.30pm to hear how to apply for the #LongitudePrizeonALS

[Longitude Prize on ALS @longitude_prize]

⏰ 2 months to go until applications close for the £7.5 million Longitude Prize on ALS.

You could help transform treatment for neurodegenerative diseases like hashtag #ALS, the most common form of motor neurone disease (#MND).

Learn more: https://t.co/wiZ71Kcsl5

[Longitude Prize on ALS @longitude_prize]

At #AIinHealth @SeanRMcClain speaks to the power of #AI to unlock novel biology in #drugdevelopment. The #LongitudePrizeonALS will bring this power to target discovery for #ALS. At the event? Come chat to us at our booth or learn more here https://t.co/sjghqgQT2V